Using reverse-phase antibody arrays for signal proteins, transcription factor arrays and gene expression microarrays, we have identified some of the major aspects in which SOD2 governs signal transduction and gene expression in pancreatic carcinoma cells. The gene discussed is SOD2; the disease is exocrine pancreatic carcinoma.